IGC Pharma (IGC) Accumulated Expenses (2011 - 2026)
IGC Pharma (IGC) recorded Accumulated Expenses of $892,000 in Q4 2026, down 35.1% from $1.37 million a year earlier and down 7.3% from the prior quarter.
Analysis
IGC Pharma (IGC) Accumulated Expenses (2011 - 2026) Analysis & Trends
Starting with Q4 2011, IGC Pharma's Accumulated Expenses history includes 44 quarters.
- Annual Accumulated Expenses has a three-year compound annual growth rate of -13.3% (FY2023 to FY2026).
- Across earlier years, Accumulated Expenses came in at $1.37 million in FY2025 (-12.3%), $1.57 million in FY2024 (+14.5%) and $1.37 million in FY2023.
- Quarterly Accumulated Expenses has ranged from $792,000 in Q1 2026 to $2.03 million in Q2 2025 over the past five years.
- On a year-over-year basis, Accumulated Expenses has declined for five consecutive quarters, with an average decline of 27.2% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $962,000 (Q3 2026), $886,000 (Q2 2026) and $792,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | IGC Pharma | 26.67 Mn | 23.92 Mn | 55,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 892,000.00 |
| Dec 31, 2025 | 962,000.00 |
| Sep 30, 2025 | 886,000.00 |
| Jun 30, 2025 | 792,000.00 |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2019 | 652,000.00 |
| Sep 30, 2019 | 677,000.00 |
| Jun 30, 2019 | 452,000.00 |
| Mar 31, 2019 | 509,000.00 |
| Sep 30, 2018 | 453,000.00 |
| Jun 30, 2018 | 274,257.00 |
| Mar 31, 2018 | 286,000.00 |
| Dec 31, 2017 | 175,200.00 |
| Sep 30, 2017 | 197,716.00 |
API Access
IGC Pharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IGC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();